Safety and immunogenicity of plant‑produced African horse sickness virus‑like particles in horses

Loading...
Thumbnail Image

Authors

Dennis, Susan J.
O’Kennedy, Martha M.
Rutkowska, Daria
Tsekoa, Tsepo
Lourens, Carina W.
Hitzeroth, Inga I.
Meyers, Ann E.
Rybicki, Edward P.

Journal Title

Journal ISSN

Volume Title

Publisher

BioMed Central

Abstract

African horse sickness (AHS) is caused by multiple serotypes of the dsRNA AHSV and is a major scourge of domestic equids in Africa. While there are well established commercial live attenuated vaccines produced in South Africa, risks associated with these have encouraged attempts to develop new and safer recombinant vaccines. Previously, we reported on the immunogenicity of a plant-produced AHS serotype 5 virus-like particle (VLP) vaccine, which stimulated high titres of AHS serotype 5-specific neutralizing antibodies in guinea pigs. Here, we report a similar response to the vaccine in horses. This is the first report demonstrating the safety and immunogenicity of plant-produced AHS VLPs in horses.

Description

Additional file 1. Virus neutralising antibody titers and VP7 iELISA scores of VLP-vaccinated and control horse sera. Pre- and postvaccination sera were assayed for neutralisation capability against AHSV 5, AHSV 8 and AHSV 4. Sheep serum from animals vaccinated with live AHS virus was used as a positive control. The pre- and post-vaccination iELISA S/P scores of serum sampled prior to vaccination and 41 days post-vaccination are shown in the right hand column. High positive control sera pooled from vaccinated horses inoculated with live attenuated vaccine (bottle 1) obtained from OBP, was used as a positive control.

Keywords

Africa, African horse sickness (AHS), Virus-like particle (VLP), Horse (Equus caballus), Safety, Immunogenicity, Vaccines

Sustainable Development Goals

Citation

Dennis, S.J., O'Kennedy, M.M., Rutkowska, D. et al. 2018, 'Safety and immunogenicity of plant‑produced African horse sickness virus‑like particles in horses', Veterinary Research, vol. 49, art. 105, pp. 1-6.